Iliac Stent Market Projected To Surpass $1.49 Billion By 2030 At 6.4% CAGR

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Iliac Stent Market?

The iliac stent market has demonstrated substantial growth in recent years. It is anticipated to expand from $1.09 billion in 2025 to $1.17 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.2%. This historical growth can be linked to the increasing occurrence of peripheral artery disease, a rising aging population, a greater embrace of endovascular procedures, the broadening scope of hospital-based vascular care, and advancements in diagnosing iliac artery lesions.

The iliac stent market is anticipated to show robust expansion over the next few years, projected to reach $1.5 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.4%. This growth throughout the forecast period is fueled by factors such as the increasing demand for minimally invasive treatments, a rising prevalence of lifestyle-related vascular disorders, broader access to interventional cardiology services, escalating healthcare expenditure in developing economies, and a greater emphasis on early vascular intervention. Significant trends expected during this period include the increased adoption of minimally invasive peripheral interventions, a growing preference for self-expandable iliac stents, the expanding use of drug-eluting and covered stents for complex lesions, a shift towards outpatient and day-care endovascular procedures, and an broadened application of iliac stents in severe and calcified lesions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15827&type=smp

Which Core Factors Are Supporting The Expansion Of The Iliac Stent Market?

The expansion of the iliac stent market is anticipated to be driven by the rising occurrence of peripheral artery diseases. Peripheral artery disease (PAD) is a circulatory condition marked by the narrowing or blockage of arteries located outside the heart and brain. The growing prevalence of peripheral artery diseases is attributed to factors such as smoking, the aging population, hypertension, and diabetes. Iliac stenting serves as an effective and minimally invasive treatment option for patients with PAD, providing improved blood flow, relief from symptoms, and prevention of complications, alongside a high success rate. For instance, in July 2023, the Society For Cardiovascular Angiography And Interventions, a US-based organization, reported that PAD affects 8-10 million Americans annually, with projections indicating 19 million Americans will have PAD by 2050. Consequently, the increasing prevalence of peripheral artery diseases propels the iliac stent market.

Which Segment Divisions Form The Structure Of The Iliac Stent Market?

The iliac stent market covered in this report is segmented –

1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types

2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions

3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users

Subsegments:

1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents

2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents

3) By Other Types: Covered Stents, Hybrid Stents

What Trends Are Impacting The Iliac Stent Market?

Leading firms within the iliac stent market are introducing novel products, for example, iCast, with the aim of enhancing patient results and lessening complication risks. The iCast-covered stent system provides a groundbreaking method for addressing iliac artery occlusive disease, delivering superior performance and lower complication potential when contrasted with conventional bare-metal stents. As an illustration, in October 2023, Getinge, a healthcare enterprise based in Sweden, declared that the iCast-covered stent system was commercially accessible in the USA, having received Food and Drug Administration (FDA) approval for managing iliac arterial occlusive disease. This approval highlights Getinge’s dedication to supplying top-tier products and assistance to American medical professionals and hospital networks for the treatment of this serious ailment.

Who Are The Companies Shaping The Iliac Stent Market Landscape?

Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

Access The Complete Iliac Stent Market Report:

https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

Which Geographic Region Represents The Largest Iliac Stent Market Share?

North America was the largest region in the iliac stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Iliac Stent Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/iliac-stent-global-market-report

Browse Through More Reports Similar to the Global Iliac Stent Market 2026, By The Business Research Company

Vascular Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Drug Eluting Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Self Expanding Stents Market Report 2026

https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795